HIGHLIGHTS
- who: Wei Seng Chng et al. from the Department of Medicine, Yong Loo Lin School of Medicine, National University of have published the research: A Factor XIa Inhibitor Engineered from Banded Krait Venom Toxin: Efficacy and Safety in Rodent Models of Arterial and Venous Thrombosis, in the Journal: Biomedicines 2022, 1679 of 20/06/2022
- what: The authors assess the in vivo efficacy and bleeding risk of rFasxiatorN17R L19E in pre-clinical animal models. Since the primary aim of the study was to establish and validate the efficacy and safety of rFasxiatorN17R,L19E in_vivo in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.